Five things to know:
- Allscripts is seeking acquisitions that increase its payer and life sciences work with its Veradigm business.
- Allscripts will use the proceeds from the sale of its hospital and large physician practices division to assist Veradigm with new life sciences and payer acquisitions.
- Allscripts reported $150.9 million in income for 2022’s second quarter, up 6.9 percent from the same quarter in 2021.
- Veradigm contributed $144.6 million in income, up 8.4 percent year-over-year.
- Allscripts posted a $5.4 million working loss for the quarter.
